MGF
Mechano Growth Factor (MGF)
Mechano Growth Factor (MGF) is a splice variant of IGF-1 (Insulin-like Growth Factor 1) that is produced locally in muscle tissue in response to mechanical stress or damage. It is primarily used in research and performance contexts to promote satellite cell activation, muscle hypertrophy, and accelerated recovery from exercise-induced muscle damage. Unlike systemic IGF-1, MGF acts locally at the site of muscle injury to initiate repair and stimulate muscle stem cell proliferation.
Mechanism of Action
MGF activates muscle satellite cells (myoblasts) through a distinct receptor-binding domain separate from the IGF-1 receptor, triggering proliferation and differentiation of these progenitor cells to repair and add myofibers. The unique C-terminal peptide of MGF upregulates cyclin D1 and activates the PI3K/Akt and MAPK/ERK signaling pathways, promoting cell survival, protein synthesis, and anti-apoptotic responses in muscle tissue. MGF also transiently suppresses myoblast differentiation to allow sufficient cell proliferation before terminal differentiation into mature muscle fibers.
Evidence by Health Goal(15 goals)
Dosing Protocols
Immediately post-workout, within 30 minutes of training the target muscle group
Cycle: 4-6 weeks on, 4 weeks off
PEGylated MGF (PEG-MGF) extends the half-life from minutes to hours and is preferred by most users; standard MGF has an extremely short half-life (~5-7 minutes) requiring site-specific intramuscular injection immediately post-exercise for meaningful activity. Subcutaneous injection is also used but intramuscular delivery to the trained muscle is considered more effective for local action.
Safety & Side Effects
MGF has a limited human clinical safety dataset; most evidence comes from animal studies and anecdotal reports from the research and performance community. While generally considered lower-risk than systemic IGF-1 due to its local action, its activity on IGF-1 receptor subtypes raises concerns about oncogenic potential with long-term use, and it is an unscheduled but largely unregulated research compound in most jurisdictions.
Possible Side Effects
- !Injection site pain, redness, or swelling, particularly with intramuscular administration
- !Hypoglycemia risk due to structural similarity to IGF-1 and partial IGF-1R activation
- !Localized muscle swelling or puffiness at injection sites
- !Fatigue or lethargy, especially at higher doses
- !Potential for disproportionate or asymmetric muscle growth if used site-specifically
- !Theoretical risk of promoting proliferation of pre-existing cancer cells via IGF-1 pathway activity
- !Headache or dizziness associated with transient hypoglycemic episodes
Interactions
- -May have additive hypoglycemic effects when combined with insulin or insulin secretagogues — monitor blood glucose closely
- -Synergistic anabolic effect when stacked with IGF-1 LR3 or growth hormone, potentially amplifying both benefits and risks
- -May enhance the anabolic effects of androgenic-anabolic steroids, increasing risk of disproportionate tissue growth
- -Theoretical interaction with mTOR-activating compounds (e.g., leucine, MK-677) due to convergent PI3K/Akt pathway signaling
- -Use caution with anticoagulants as IGF-1 pathway activation may influence platelet aggregation and vascular biology
Cost & Where to Buy
Standard MGF is generally cheaper but its extremely short half-life makes PEG-MGF (PEGylated) the more practical and commonly purchased form, which costs more per vial. Prices vary significantly by vendor purity, lyophilization quality, and whether PEGylated or standard; research-grade vials typically contain 1-2mg each.
Search on Amazon